# Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome

**Authors:** Giuseppe Quaranta, Angelo Giovanni Icro Maremmani, Giulio Perugi

PMC · DOI: 10.1155/2015/273192 · 2015-10-01

## TL;DR

A young woman with Turner syndrome showed symptoms of bipolar disorder but was later diagnosed with an autoimmune brain condition and improved with treatment.

## Contribution

Highlights a rare case linking anti-AMPA-receptor encephalitis with psychiatric symptoms in a patient with Turner syndrome.

## Key findings

- The patient showed marked improvement after treatment with memantine and valproic acid.
- Autoimmune encephalitis was diagnosed despite initial presentation as treatment-resistant bipolar disorder.
- Turner syndrome may be a risk factor for autoimmune conditions like encephalitis.

## Abstract

Background. Autoimmune encephalitis is a disorder characterised by the subacute onset of seizures, short-term memory loss, and psychiatric and behavioural symptoms. Initially, it was recognised as a paraneoplastic disorder, but recently a subgroup of patients without systemic cancer was identified. Case Description. We describe a 20-year-old woman with Turner syndrome presenting with a treatment-resistant rapid cycling bipolar disorder with cognitive impairment. She was diagnosed with anti-AMPA-receptor encephalitis. She showed marked improvement after starting memantine and valproic acid. Conclusion. This case description emphasises the importance of timely recognition of autoimmune limbic encephalitis in patients with psychiatric manifestations and a possible predisposition to autoimmune conditions, in order to rule out malignancy and to quickly initiate treatment.

## Linked entities

- **Chemicals:** memantine (PubChem CID 4054), valproic acid (PubChem CID 3121)
- **Diseases:** Turner syndrome (MONDO:0019499), bipolar disorder (MONDO:0004985), autoimmune encephalitis (MONDO:0020640), autoimmune limbic encephalitis (MONDO:0850097)

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}
- **Diseases:** gonadal digenesis (MESH:D006058), cognitive deficits (MESH:D003072), disorganization (MESH:D012562), lupus (MESH:D008180), hyperactive (MESH:D006948), language disabilities (MESH:D007806), malignancy (MESH:D009369), genetic disorder (MESH:D030342), Hashimoto thyroiditis (MESH:D050031), alopecia areata (MESH:D000506), neurological (MESH:D009461), neurological diseases (MESH:D020271), brain damage (MESH:D001925), anxiety (MESH:D001007), agitation (MESH:D011595), type 1 diabetes mellitus (MESH:D003922), depressive and (MESH:D003866), limbic encephalitis (MESH:D020363), organic disease (MESH:D000092124), psoriasis (MESH:D011565), temporal lobe seizures (MESH:D004833), paranoidism (MESH:D010259), mental disorder (MESH:D001523), oligohydramnios (MESH:D016104), motor tic (MESH:D020323), tremors (MESH:D014202), catatonic features (MESH:D012560), neuronal death (MESH:D009410), juvenile rheumatoid arthritis (MESH:D001171), TC (OMIM:275350), vitiligo (MESH:D014820), memory impairment (MESH:D008569), paraneoplastic disorder (MESH:D010257), rigidity (MESH:D009127), bipolar (MESH:D001714), confusion (MESH:D003221), bipolar, schizoaffective, (MESH:D011618), encephalitis (MESH:D004660), speech disorders (MESH:D013064), enuresis (MESH:D004775), affective psychosis (MESH:D000341), Mood (MESH:D019964), Autoimmune encephalitis (MESH:D020274), ulcerative colitis (MESH:D003093), schizophrenia (MESH:D012559), encephalitic syndrome (MESH:D010301), bradykinesia (MESH:D018476), infertility (MESH:D007246), disruptive behaviour (MESH:D019958), Extrapyramidal symptoms (MESH:D001480), Addison's disease (MESH:D000224), motor retardation (MESH:D019957), amenorrhea (MESH:D000568), CNS diseases and (MESH:D002493), dementia (MESH:D003704), hypomania (MESH:D000087122), Coeliac disease (MESH:D004194), Autoimmune diseases (MESH:D001327), TS (MESH:D014424), hyperprolactinemia (MESH:D006966)
- **Chemicals:** AMPA (-), Glutamate (MESH:D018698), risperidone (MESH:D018967), valproic acid (MESH:D014635), Memantine (MESH:D008559), N-Methyl-D-Aspartate (MESH:D016202), chlorpromazine (MESH:D002746), benzodiazepines (MESH:D001569)
- **Species:** Homo sapiens (human, species) [taxon 9606], Equus caballus (domestic horse, species) [taxon 9796]

---
Source: https://tomesphere.com/paper/PMC4606164